Hereditary Hemorrhagic Telangiectasia (HHT) Center
Department of Health and Human Services Health Resources and Services Administration
Posted on:
Application Deadline:
Expired
Type
Fellowships
Reference Number
HRSA-22-145
The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.
Categories: Health.
Categories: Health.
United States